Bharat Biotech's US partner Ocugen Inc said that the company will no longer pursue an Emergency Use Authorization (EUA) for COVAXIN and the US Food and Drug Administration (FDA) has recommended that the company go for the Biologics Licence Applicatio ...
Hyderabad-based vaccine manufacturer Bharat Biotech, which is carrying out its phase 3 trial will publish the data in July following that the company will be applying for the full licensure of COVAXIN. ...
The Central Industrial Security Force will take over security of the Hyderabad campus of Bharat Biotech, one of the major COVID-19 vaccine manufacturers in the country, informed CISF on Tuesday. ...
Brazil has approved the import of Bharat Biotech manufactured COVID-19 vaccine Covaxin into the country with regulations, informed ANVISA on Friday. ...
Delhi government on Friday told the Delhi High Court that Bharat Biotech supplied only 1.5 lakh doses of COVID-19 vaccine 'Covaxin' in May against a promise of five lakh doses. ...